PCSK9 has recently been implicated as a critical mediator of the immune response to sepsis, whereby PCSK9 inhibits hepatic clearance of lipopolysaccharide in the liver leading to increased inflammation and worse outcomes (2–4). This evidence concerns the gene PCSK9 and Sepsis.